Edition:
United States

Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

1.45USD
18 Jan 2017
Change (% chg)

-- (--)
Prev Close
$1.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
75,199
52-wk High
$2.89
52-wk Low
$1.03

ATHX.OQ

Chart for ATHX.OQ

About

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating... (more)

Overall

Beta: -0.14
Market Cap(Mil.): $123.97
Shares Outstanding(Mil.): 85.50
Dividend: --
Yield (%): --

Financials

  ATHX.OQ Industry Sector
P/E (TTM): -- 45.86 30.46
EPS (TTM): -0.05 -- --
ROI: -26.79 -1.27 14.82
ROE: -29.30 -1.00 16.24

BRIEF-Athersys reports Q3 loss per share $0.07

* Q3 loss per share $0.07 Source text for Eikon: Further company coverage:

Nov 09 2016

BRIEF-Athersys, FDA agree on design for ischemic stroke late-stage study

* Athersys receives FDA agreement under special protocol assessment for phase 3 study of multistem treatment for ischemic stroke Source text for Eikon: Further company coverage:

Sep 28 2016

BRIEF-Athersys qtrly loss per share $0.08

* Qtrly loss per share $0.08 Source text for Eikon: Further company coverage:

Aug 09 2016

Earnings vs. Estimates